Anschutz Medical Campus

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee

Retrieved on: 
Thursday, March 28, 2024
Novartis, Acute lymphoblastic leukemia, Head, LG, Translational research, Urology, Oncology, Drug discovery, Executive, LG Chem, Lung, Anschutz Medical Campus, Committee, SRL Diagnostics, University, Laboratory, Doctor of Philosophy, RWTH Aachen University, Senior, Radiopharmaceutical, European Medicines Agency, ARUP Laboratories, Therapy, Drug development, Pharmacology, Pharmaceutical industry

BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer. Dr. Braendle is a life sciences executive with experience spanning from early drug discovery to the launch of small molecules, biologics, radiopharmaceuticals, gene and cell therapies, and medical device development.

Key Points: 
  • BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer.
  • “We are delighted to have Dr. Braendle join the AVEO Oncology team particularly at this important juncture as we seek to become a global top 20 oncology leader,” said Michael P. Bailey, President and Chief Executive Officer of AVEO Oncology, an LG Chem company.
  • Today, AVEO Oncology, an LG Chem company, and LG Chem Life Sciences also announced the formation of its Scientific Advisory Committee (“Committee”).
  • The Scientific Advisory Committee is comprised of several leading cancer experts, including:
    Professor and Deputy Chair for Translational Research, Department of Gastrointestinal Medical Oncology
    University of Colorado Cancer Center, Aurora

Global Down Syndrome Foundation Launches Matching “21 for 21” Campaign for World Down Syndrome Day with Support from the Safeway Foundation

Retrieved on: 
Thursday, March 14, 2024
Anschutz Medical Campus, Congress, Down syndrome, United, Patient, Research, United Nations, University, Guideline, Prenatal development, Bangladesh Technical Education Board

World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.

Key Points: 
  • World Down Syndrome Day was promulgated by the United Nations in 2012 and is celebrated in 190 countries.
  • To learn more about the Global Down Syndrome Foundation and World Down Syndrome Day, visit www.globaldownsyndrome.org/world-down-syndrome-day-month .
  • The Global Down Syndrome Foundation (GLOBAL) is the largest non-profit in the U.S. working to save lives and dramatically improve health outcomes for people with Down syndrome.
  • GLOBAL’s widely circulated medical publications include GLOBAL Medical Care Guidelines for Adults with Down Syndrome , Prenatal & Newborn Down Syndrome Information , and the award-winning Down Syndrome World™ magazine.

Four New Retailers Coming to 21 Fitzsimons and The Fremont on the Anschutz Medical Campus

Retrieved on: 
Tuesday, March 19, 2024
Commercial Building & Real Estate, Construction & Property, Restaurant, Bar, Wine & Spirits, Specialty, REIT, Retail, Residential Building & Real Estate, Anschutz Medical Campus, Patronage, Siren, City, Sable, Heart, Drink, AIRC, AIR, Amusement park

Apartment Income REIT Corp. (NYSE: AIRC) (“AIR” or “AIR Communities”) is thrilled to announce the arrival of four new retailers at 21 Fitzsimons and The Fremont, two premier apartment communities located at the heart of the Anschutz Medical Campus.

Key Points: 
  • Apartment Income REIT Corp. (NYSE: AIRC) (“AIR” or “AIR Communities”) is thrilled to announce the arrival of four new retailers at 21 Fitzsimons and The Fremont, two premier apartment communities located at the heart of the Anschutz Medical Campus.
  • These exciting additions will offer a diverse range of services, catering to the needs of residents, nearby workers, and the greater community.
  • With a passion for experimentation and a dedication to quality, Milieu Fermentation aims to provide a one-of-a-kind taproom experience.
  • “The Anschutz Medical Campus and Fitzsimons Innovation Community are important economic drivers for the City of Aurora and the State of Colorado.

Celebrating Excellence in Anatomy: AAA Awards Distinguished Members

Retrieved on: 
Thursday, February 8, 2024
Pennsylvania State University, Harvard Medical School, California University, Cell biology, The Anatomical Record, Developmental Dynamics, Stanford University, North Carolina State University, Boston Children's Hospital, Public health, School, Cell, Conference, Associate, Medical education, Mentorship, McGill University, Human body, Hospital, Biomedical sciences, Pediatrics, Anatomical Sciences Education, Forensic anthropology, Anschutz Medical Campus, Dental school, Student, University, AAA, Genetics, Outline of health sciences, Research, Physiology, City University, Chemical engineering, Arkansas College, Division, Orthopedic surgery, UCSF, Dentistry

ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients. Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery. 

Key Points: 
  • ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients.
  • Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery.
  • The AAA awards program provides over $650,000 in awards, research grants, and scholarships annually.
  • "Being recognized by my AAA idols, mentors, and peers is a cherished honor, reaffirming my commitment to fostering curiosity, deep understanding, and innovation in anatomy education."

Global Down Syndrome Foundation President & CEO Michelle Sie Whitten to be Inducted into the Denver Business Journal Hall of Fame for Her Transformative Research and Medical Work for Children and Adults with Down Syndrome

Retrieved on: 
Thursday, January 25, 2024
Jesuits, Network affiliate, Hope, Anschutz Medical Campus, Research, American City Business Journals, Life, Face, CO, Happiness, University, Government, Intellectual, Down syndrome, DBJ, Child, Regis University, Parent, Infinity Park, Denver Health Medical Center, Bangladesh Technical Education Board, Anna, Darkness, Growth

Whitten will be joining 40 accomplished young professionals who will receive this prestigious annual recognition award the night of the event.

Key Points: 
  • Whitten will be joining 40 accomplished young professionals who will receive this prestigious annual recognition award the night of the event.
  • From 1993 to 2004 Whitten worked in the TV industry for cable pioneers Peter Barton, her father, John J. Sie and others.
  • In 2003 Whitten gave birth to her first child, Sophia, who happens to have Down syndrome.
  • From that moment, Whitten has dedicated her life to improving the lives of people with Down syndrome through research, medical care, and government advocacy.

Crnic Institute Awarded Anschutz Acceleration Initiative Grant for Pioneering Research Aimed at Improving the Health of Children with Down Syndrome

Retrieved on: 
Thursday, January 18, 2024
Assistant professor, Network affiliate, Anschutz Medical Campus, Research, Database, AAI, Congress, Philip Anschutz, Associate professor, Health, Rheumatology, JAK, CO, Anschütz, University, MSCS, Quality of life, Chromosome, NIH, Colorado State University, Doctor of Philosophy, T21, Crnić, Inflammation, Doctor of Psychology, Clinical trial, Anna, Immune system, Pharmaceutical industry

“Receiving this grant is deeply gratifying,” says Dr. Joaquín Espinosa, Professor in Pharmacology and Executive Director of the Crnic Institute.

Key Points: 
  • “Receiving this grant is deeply gratifying,” says Dr. Joaquín Espinosa, Professor in Pharmacology and Executive Director of the Crnic Institute.
  • “Everyone at the Crnic Institute, GLOBAL and all our Affiliates have worked so hard in the last ten years to take our remarkable findings from the Petri dish and parlay that into benefit for people with Down syndrome.
  • Key outstanding questions specific to individuals with Down syndrome will be addressed:
    What are the impacts of interferon hyperactivity during early childhood?
  • From over 165 letters of intent and ultimately 56 full proposals, 9 research projects were funded.

Global Down Syndrome Foundation Raises $2.5 Million and Honors Co-Founder Anna Sie at Their Be Beautiful Be Yourself Fashion Show

Retrieved on: 
Tuesday, November 21, 2023
Denver Nuggets, Down syndrome, ABC, Ambassador, Dumb, Bobby Farrelly, Research, Golf, Intellectual, Cancer, NBC, Beauty, Denver Broncos, Love, NFL, Anschutz Medical Campus, Dumb and Dumber, Matsuhisa, Film industry

DENVER, Nov. 21, 2023 (GLOBE NEWSWIRE) -- On Saturday, November 18, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show , held at the Sheraton Denver Downtown Hotel.

Key Points: 
  • DENVER, Nov. 21, 2023 (GLOBE NEWSWIRE) -- On Saturday, November 18, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show , held at the Sheraton Denver Downtown Hotel.
  • The star-studded evening was dedicated to beloved GLOBAL Co-Founder, Anna Sie, who sadly passed away on September 20 after a long and valiant battle with cancer.
  • Anna made it her life's mission to ensure her granddaughter, Sophia, and all people with Down syndrome have a brighter future.
  • “Tonight, as we gather to celebrate the brilliance and beauty of individuals with Down syndrome, we hold my mother, Anna Sie, in our hearts," said Michelle Sie Whitten, President and CEO.

New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD)

Retrieved on: 
Tuesday, November 14, 2023
ICH, Rivaroxaban, Buerger's test, Research, Safety, Johnson & Johnson, Thrombin, Food, PAD, DPI, American Heart Association, AHA, Risk, Amputation, CAD, Patient, ALI, Myocardial infarction, Intracerebral hemorrhage, Coagulation, LER, TIMI, FDA, Medical Affairs Bureau, Division, Janssen Pharmaceuticals, Comorbidity, MACE, Vascular disease, Stroke, Standard of care, University, Bleeding, Aspirin, EGFR, Janssen, Disability, Anschutz Medical Campus, Metabolism, Pharmaceutical industry

TITUSVILLE, N.J., Nov. 14, 2023 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of XARELTO® (rivaroxaban [2.5 mg twice daily plus aspirin 100 mg once daily]) over standard of care (aspirin alone). Data from the two analyses demonstrate the role of XARELTO® in treating both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD). Results were presented at the American Heart Association's (AHA) 2023 Scientific Sessions, hosted in Philadelphia, Pennsylvania, November 11-13, 2023.

Key Points: 
  • "These analyses reinforce the consistency of the favorable benefit-risk profile of XARELTO® plus aspirin for patients with vascular disease, regardless of comorbidity.
  • In fragile patients treated with XARELTO® plus aspirin, 6.2% of patients experienced a MALE compared to 10.3% of patients treated with placebo.
  • In patients with PAD only, 11% of patients treated with XARELTO® plus aspirin experienced a MACE versus 9.8% of patients treated with placebo.
  • Overall, the safety of XARELTO® plus aspirin in patients with PAD was consistent regardless of CAD with no significant interactions.

NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer

Retrieved on: 
Monday, October 30, 2023
Patient, Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, Gold, Policy, Weather, NCI, Publishing, Visit, Health, Fatigue, Cancer-related fatigue, Vomiting, Doctor of Philosophy, Palliative care, Nausea, Quality of life, University of Wisconsin Carbone Cancer Center, Caregiver, Disease, Medicine, National Cancer Institute, NCCN, University, Anschutz Medical Campus, Anemia, Diagnosis, Book, MS, Pharmaceutical industry, Nursing, Medical device, Residential care, Medical imaging, MD, Cancer

PLYMOUTH MEETING, Pa., Oct. 30, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual needs and priorities. Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care, part of an ongoing expansion of supportive care resources. The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care.

Key Points: 
  • Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care , part of an ongoing expansion of supportive care resources.
  • The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care .
  • All guides are available free-of-charge at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App .
  • Dr. Campbell stressed that palliative care is an important part of comprehensive cancer care regardless of age, cancer stage, or the need for other therapies.

NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer

Retrieved on: 
Monday, October 30, 2023
Patient, Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, Gold, Policy, Weather, NCI, Publishing, Visit, Health, Fatigue, Cancer-related fatigue, Vomiting, Doctor of Philosophy, Palliative care, Nausea, Quality of life, University of Wisconsin Carbone Cancer Center, Caregiver, Disease, Medicine, National Cancer Institute, NCCN, University, Anschutz Medical Campus, Anemia, Diagnosis, Book, MS, Pharmaceutical industry, Nursing, Medical device, Residential care, Medical imaging, MD, Cancer

PLYMOUTH MEETING, Pa., Oct. 30, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual needs and priorities. Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care, part of an ongoing expansion of supportive care resources. The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care.

Key Points: 
  • Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care , part of an ongoing expansion of supportive care resources.
  • The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care .
  • All guides are available free-of-charge at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App .
  • Dr. Campbell stressed that palliative care is an important part of comprehensive cancer care regardless of age, cancer stage, or the need for other therapies.